CytoDyn

(OTC) CYDY

Current Price$0.31

Market Cap$419.23M

Since IPO (2005)-53%

5 Year-90%

1 Year+4%

1 Month+18%

CytoDyn Financials at a Glance

Market Cap

$419.23M

Revenue (TTM)

$5.92M

Net Income (TTM)

$38.79M

EPS (TTM)

$-0.03

P/E Ratio

-9.59

Dividend

$0.00

Beta (Volatility)

0.88 (Low)

Dividend

$0.00

Beta (Volatility)

0.88 (Low)

Price

$0.31

Volume

2,818,222

Open

$0.30

Price

$0.31

Volume

2,818,222

Open

$0.30

Previous Close

$0.31

Daily Range

$0.29 - $0.32

52-Week Range

$0.20 - $0.45

Dividend

$0.00

Beta (Volatility)

0.88 (Low)

Price

$0.31

Volume

2,818,222

Open

$0.30

Previous Close

$0.31

Daily Range

$0.29 - $0.32

52-Week Range

$0.20 - $0.45

CYDY News

3 Biotechs to Avoid Like the Plague in July

Zhiyuan SunJul 6, 2021

What's Behind This Wild-Card Coronavirus Stock?

Zhiyuan SunJun 8, 2021

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About CytoDyn

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jacob P. Lalezari, MD

Website

www.cytodyn.com

Headquarters

Vancouver, WA 98660, US

CYDY Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

66%

Return on Assets

-2%

Earnings Yield

-10.43%

Dividend Yield

0.00%

Payout Ratio

-2.85%

Stock Overview

Market Cap

$419.23M

Shares Outstanding

1.37B

Volume

2.82M

Avg. Volume

1.83M

Financials (TTM)

Gross Profit

$18.00K

Operating Income

$11.32M

EBITDA

$8.62M

Operating Cash Flow

$8.77M

Capital Expenditure

$0.00

Free Cash Flow

$8.77M

Cash & ST Invst.

$11.90M

Total Debt

$27.34M

CytoDyn Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$4.00K

+20.0%

Gross Margin

0.00%

N/A

Market Cap

$419.23M

N/A

Market Cap/Employee

$46.58M

N/A

Employees

N/A

Net Income

$4.69M

+1.4%

EBITDA

$6.30M

-80.0%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Net Cash

$11.58M

-6.1%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$27.20M

+79900.0%

Short Term Debt

$11.75M

-56.9%

Return on Assets

-2.10%

N/A

Return on Invested Capital

65.89%

N/A

Free Cash Flow

$5.52M

-11.4%

Operating Cash Flow

$5.52M

-11.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CLVLYClinuvel Pharmaceuticals Limited

CLVLYClinuvel Pharmaceuticals Limited$6.70+0.00%

NWBONorthwest Biotherapeutics, Inc.

NWBONorthwest Biotherapeutics, Inc.$0.20+0.00%

CLVLFClinuvel Pharmaceuticals Limited

CLVLFClinuvel Pharmaceuticals Limited$6.27+0.00%

CMVLFCellectis S.A.

CMVLFCellectis S.A.$3.08-30.00%

BOVNFBioInvent International AB (publ)

BOVNFBioInvent International AB (publ)$3.29+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

TSLATesla

TSLATesla$390.82+0.02%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About CYDY

What is the current price of CytoDyn?

CytoDyn is trading at $0.31 per share.

What is the 52-week range for CytoDyn?

Over the past 52 weeks, CytoDyn has traded between $0.21 and $0.45.

How much debt does CytoDyn have?

As of the most recent reporting period, CytoDyn reported total debt of $27.23M.

How much cash does CytoDyn have on hand?

CytoDyn reported $15.65M in cash and cash equivalents in its most recent financial results.

What is CytoDyn’s dividend yield?

CytoDyn does not currently have a dividend yield.

CytoDyn

CytoDyn Financials at a Glance

CYDY News

3 Biotechs to Avoid Like the Plague in July

What's Behind This Wild-Card Coronavirus Stock?

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About CytoDyn

CYDY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

CytoDyn Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CYDY

What is the current price of CytoDyn?

What is the 52-week range for CytoDyn?

How much debt does CytoDyn have?

How much cash does CytoDyn have on hand?

What is CytoDyn’s dividend yield?

Premium Investing Services